Home › Research › Risk factors
Inequities in dementia diagnosis and care: insights from a universal health care system
Claire Godard‐Sebillotte, Sanjna Navani, Wang Xia, Geneviève Arsenault‐Lapierre, Nadia Sourial, Amélie Quesnel‐Vallée, Louis Rochette, Victoria Kubuta Massamba et al.. Alzheimer s & Dementia, 2025-12-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Of the 193,834 community-dwelling people with a new diagnosis of dementia, around 20% belonged to each material deprivation category. Age-standardised rates of 15/23 indicators differed across SES. People from most deprived areas had more hospitalisations, emergency department visits, potentially inappropriate medication prescriptions, and higher 1-year mortality, though they had higher care continuity. Conversely, rates were comparable across groups for the prescription of dementia-specific medications, and primary care visits. Patterns of primary care use varied across material deprivation and neighborhood racialization; with higher use in wealthiest neighborhoods, the highest use being in the most racialized ones. Despite global findings of higher dementia incidence in lower SES, we found similar incidence across SES. These findings indicate that there is likely severe under-diagnosis of dementia in more materially deprived neighborhoods. Stark differences across SES in service use by people with dementia may indicate different health needs and/or allude to pervasive health inequities. An intersectional lens allows for a nuanced description of inequalities. These results can inform policies to offer equitable, appropriate, and needs-based care to all people living with dementia.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. This study found differences by socioeconomic status in hospital use, emergency visits, potentially inappropriate medications and mortality among people with a new dementia diagnosis, and suggests likely under-diagnosis in more deprived areas. It is about health inequities in care, not about treating, curing or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Godard‐Sebillotte, C., Navani, S., Xia, W., Arsenault‐Lapierre, G., Sourial, N., Quesnel‐Vallée, A., et al. (2025). Inequities in dementia diagnosis and care: insights from a universal health care system. Alzheimer s & Dementia. https://doi.org/10.1002/alz70860_107449
Vancouver
Godard‐Sebillotte C, Navani S, Xia W, Arsenault‐Lapierre G, Sourial N, Quesnel‐Vallée A, et al. Inequities in dementia diagnosis and care: insights from a universal health care system. Alzheimer s & Dementia. 2025. doi:10.1002/alz70860_107449. PMID: 41434717.
BibTeX
@article{godardsebillotte2025-41434717,
author = {Godard‐Sebillotte, Claire and Navani, Sanjna and Xia, Wang and Arsenault‐Lapierre, Geneviève and Sourial, Nadia and Quesnel‐Vallée, Amélie and Rochette, Louis and Massamba, Victoria Kubuta and others},
title = {{Inequities in dementia diagnosis and care: insights from a universal health care system}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70860_107449},
pmid = {41434717},
url = {https://doi.org/10.1002/alz70860_107449}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Of the 193,834 community-dwelling people with a new diagnosis of dementia, around 20% belonged to each material deprivation category.
- Age-standardised rates of 15/23 indicators differed across SES.
- People from most deprived areas had more hospitalisations, emergency department visits, potentially inappropriate medication prescriptions, and higher 1-year mortality, though they had higher care continuity.
- Conversely, rates were comparable across groups for the prescription of dementia-specific medications, and primary care visits.
- Patterns of primary care use varied across material deprivation and neighborhood racialization; with higher use in wealthiest neighborhoods, the highest use being in the most racialized ones.
Why it matters
This study found differences by socioeconomic status in hospital use, emergency visits, potentially inappropriate medications and mortality among people with a new dementia diagnosis, and suggests likely under-diagnosis in more deprived areas. It is about health inequities in care, not about treating, curing or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Study designcohort study
- Evidence strengthModerate
How this study scored 41/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Isabelle Vedel: h-index 39 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | McGill University: institution h-index 1,373 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41434717) |
| Free to read | 2 / 2 | Free to read |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70860_107449
- PubMed: 41434717
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk factors from nearby years
Also tagged “prevalence”
1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.